NSEShareholders meeting4d ago · 27 Oct 2026, 02:14 pm
Shareholders meeting
Privi Speciality Chemicals Limited · PRIVISCL
✦ AI SummaryM&A
Privi Speciality Chemicals Limited has informed the Exchange regarding Proceedings of Court Convened General Meeting held on October 27, 2026, where the Scheme of Amalgamation of Privi Fine Sciences Private Limited and Privi Biotechnologies Private Limited with Privi Speciality Chemicals Limited was approved by the Equity Shareholders.
Analysis Scores
Earnings Impact5/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk3/10
Balance Sheet Risk4/10
Liquidity Impact7/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Privi Speciality Chemicals Limited has informed the Exchange regarding Proceedings of Court Convened General Meeting held on October 27, 2026
Attachments (1)
📄pdf
Download →
FAIRCHEMDP_27102026141403_ProceedingofNCLTMeetingsigned.pdf
View document text
Date: October 27, 2026
To, To,
The Manager (CRD) The Manager - Listing Department
BSE Limited National Stock Exchange of India Ltd
Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot no. C/l, G Block,
Dalal Street, Fort, Bandra-Kurla Complex, Bandra (East)
Mumbai-400001 Mumbai-400051
Scrip Code: 530117 Symbol: PRIVISCL
Subject: Summary of the Proceedings of the NCLT Convened Meeting of the Equity Shareholders of
the Company held on Tuesday, October 27, 2026
Dear Sir/ Madam,
Pursuant to the Orders dated September 7, 2026 passed by the Hon'ble National Company Law
Tribunal, Mumbai Bench ("NCLT"), a meeting of the Equity Shareholders of the Company was held on
Tuesday, October 27, 2026 at 12:30 p.m. (1ST) ("Meeting") at deemed venue for the purpose of
considering, and if thought fit, approving the proposed Scheme of Amalgamation of Privi Fine Sciences
Private Limited, the Transferor Company 1 and Privi Biotechnologies Private Limited, the Transferor
Company 2 with Privi Speciality Chemicals Limited, the Transferee Company ("Scheme") under
sections 230 to 232 and other applicable provisions of the Companies Act, 2013 ("Act") along with the
Companies (Compromises, Arrangements and Amalgamations) Rules, 2016 ("Merger Rules") and
other applicable rules under the Act.
We would like to inform that the business contained in the Notice was transacted and passed by the
Equity Shareholders with requisite majority.
As required under the Para A of Part A to Schedule III of Regulation 30 of the SEBI (Listing Obligations
and Disclosure Requirements) Regulation, 2015, we submit herewith proceedings of the Meeting of
the Members of the Company held on Tuesday, October 27, 2026, at 12:30 p.m. through Video
Conference (VC) / Other Audio Visual Means (OAVM) and concluded at 01:13 p.m.
MEMBERS PRESENT:
Members present through VC/OAVM: 57
DATE, TIME AND VENUE OF THE MEETINGS
The Meeting of the Equity Shareholders of the Company convened pursuant to the Order of NCLT was
held on Tuesday, October 27, 2026, at 12:30 p.m. (1ST) through Video Conferencing / Other Audio-
Visual Means ("VC/OAVM"). The deemed venue for the meeting was the Registered Office of the
Transferee Company viz., Privi House, Plot No A-71, TTC, Thane Belapur Road, Kopar Khairane, Navi
Mumbai, Thane, 400710
PROCEEDINGS IN BRIEF
Mr. Mohan Prasad Tiwari, Chairman appointed by the Hon'ble National Company Law Tribunal,
Mumbai Bench ("NCLT"), occupied the Chair and informed the Equity shareholders present, that he-^3nc^
has been appointed as the Chairman of the Meeting vide NCLT Order dated September 7, 2026. /<§^ <",
ISO 9001:2015
PRM SPECIALIF»' CHEMICALS LIMITED "fl.'/nba;:^
15014001:2015
18045001:2018 Knowledge Centre & Regd. Office : Privi House, A-71, TTC, Thane Belapur Road, Near Kopar Khairane Railway Station,
BUREAU VERITAS Navi Mumbai - 400 710. India | Tel.: +91 22 68713200 / 33043500 / 33043600 / 27783040 / 27783041 / 27783045
Certification Fax: +91 2227783049/68713232 | Email: enquiry@privi.co.in | Web: www.privi.com | GIN: L15140MH1985PLC286828
The Chairman welcomed all the Members and informed them that the meeting was being conducted
through Video Conferencing (VC)/Other Audio-Visual Means (OAVM), in accordance with the
applicable circulars issued by the Ministry of Corporate Affairs (MCA) and the Securities and Exchange
Board of India (SEBI), and in compliance with the applicable provisions of the Companies Act, 2013,
read with the rules made thereunder, as amended from time to time, and the SEBI (Listing Obligations
and Disclosure Requirements) Regulations, 2015, as amended. The registered office of the Company
was deemed to be the venue of the NCLT-convened meeting.
As the meeting was held through VC/OAVM and there was no physical attendance of Members, the
Members were informed that the requirement of appointing proxies was not applicable.
The Chairman informed that pursuant to the Orders dated September 7, 2026 passed by the Hon'ble
National Company Law Tribunal, Mumbai Bench, the Meeting of the Equity Shareholders of the
Company has been convened to approve the Scheme of Amalgamation of Privi Fine Sciences Private
Limited, the Transferor Company 1 and Privi Biotechnologies Private Limited, the Transferor Company
2 with Privi Speciality Chemicals Limited, the Transferee Company.
Total 57 members were present for this Meeting. The requisite quorum of members being present, the
meeting was called to order.
The Chairman informed that Mrs. Dipti Arpit Nagori, Practicing Company Secretary (Membership No.
F8603 and COP No. 9917) has been appointed as the Scrutinizer for the Meeting to scrutinize the e-
voting during the meeting and the remote e-voting process and to ensure that meeting is conducted
in a fair and transparent manner.
The Chairman then addressed the Members and informed regarding the Scheme of Amalgamation and
its rationale. With the consent of the Members, the Notice of the Meeting was taken as read.
The Chairman placed the following items of business, as per the notice of the Meeting dated
September 11, 2026, for the approval of the members:
Sr. No. | Resolution Type of Resolution
Special Business
Approval of the Scheme of Amalgamation of Privi Fine Sciences
Private Limited, the Transferor Company 1 and Privi Biotechnologies
1. Special Resolution
Private Limited, the Transferor Company 2 with Privi Speciality
Chemicals Limited.
The Chairman then invited the Members who had registered themselves as speakers and those who
wanted to speak at the meeting, to ask questions and express their views.
Four speakers asked few questions. Thereafter, the management thanked the speaker for their concern
and interest in the Company and responded to all the questions raised by the shareholder.
It was announced that the results of remote e-vottng and e-voting during the meeting, would be
declared on receiptof the Scrutinizer's Report and shall be placed on the website of the Company, the
websiteofMUFG Intime India Private Limited, the agency providing e-voting facility and would also be /
RECD.
PRIVI SPECIALITY CHEMICALS LIMITED • i O^iCE
1809001:2015 ^
13014001:2015
18045001:2018 Knowledge Centre & Regd. Office : Privi House, A-71, TTC, Thane Belapur Road, Near Kopar Khairane Railway Station;; •—'^
BUREAU VERITAS Navi Mumbai - 400 710. India | Tel. : +91 22 68713200 / 33043500 / 33043600 / 27783040 / 27783041 / 27783045 •..^
Certification Fax: +91 2227783049/68713232 | Email: enquiry@privi.co.in | Web: www.privi.com | CIN:L15140MH1985PLC286828
filed with Stock Exchanges. These resolutions shall be deemed to have been passed at this meeting
upon declaration of results.
The Chairman, thereafter, thanked all the Members and management team for their participation at
the Meeting. He informed the members that the e-voting process will continue for 15 minutes after
the conclusion of the meeting and will be disabled automatically thereafter.
The Meeting concluded at 01:13 p.m. 1ST.
Yours faithfully,
For Privi Speciality Chemicals Limited
Ashwini Saumil Shah ^ OFHCE Jc S; ]
Company Secretary & Compliance Officer ^^
PRIVI SPECIALITY CHEMICALS LIMITED
1809001:2015
13014001:2015
18045001:2018 Knowledge Centre & Regd. Office : Privi House, A-71, TTC, Thane Belapur Road, Near Kopar Khairane Railway Station,
BUREAU VERITAS Navi Mumbai - 400 710. India | Tel.: +91 22 68713200 / 33043500 / 33043600 / 27783040 / 27783041 / 27783045
Certification Fax: +91 2227783049/68713232 | Email: enquiry@privi.co.in | Web; www.privi.com | GIN: L15140MH1985PLC286828